Who owns AEROVATE THERAPEUTICS INC?
- Ticker: AVTE
- CUSIP Number: 008064107
Tip: Access positions for across all investors
Analyze quarterly positions in Aerovate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aerovate Therapeutics stock
Who bought or sold AEROVATE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 8.3M | $244M | 0% | Mar 2024 |
|
| Sofinnova Ventures | 3.8M | $111M | 0% | Mar 2024 |
|
| Atlas Venture Life Science Advisors | 2.0M | $60M | 0% | Mar 2024 |
|
| Baker Bros. Advisors | 1.7M | $50M | 0% | Mar 2024 |
|
| Frazier Life Sciences Management | 1.2M | $36M | 0% | Mar 2024 |
|
| Cormorant Asset Management | 1.1M | $32M | -12% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 888k | $26M | -14% | Mar 2024 |
|
| BlackRock | 710k | $21M | 4% | Mar 2024 |
|
| Vanguard Group | 672k | $20M | 7% | Mar 2024 |
|
| OrbiMed Advisors | 565k | $17M | -25% | Mar 2024 |
|
| FMR | 538k | $16M | 2% | Mar 2024 |
|
| Eventide Asset Management | 446k | $13M | 3558% | Mar 2024 |
|
| Octagon Capital Advisors | 404k | $12M | 0% | Mar 2024 |
|
| Point72 Asset Management | 400k | $12M | -9% | Mar 2024 |
|
| Ikarian Capital | 368k | $11M | 100% | Mar 2024 |
|
| Geode Capital Management | 282k | $8.3M | 13% | Mar 2024 |
|
| Ensign Peak Advisors | 262k | $7.8M | 1648% | Mar 2024 |
|
| Woodline Partners | 200k | $5.9M | 100% | Mar 2024 |
|
| Superstring Capital Management | 110k | $3.3M | 100% | Mar 2024 |
|
| Northern Trust | 99k | $2.9M | -11% | Mar 2024 |
|
| Exome Asset Management | 99k | $2.9M | 100% | Mar 2024 |
|
| Boothbay Fund Management | 98k | $2.9M | 100% | Mar 2024 |
|
| Nantahala Capital Management | 91k | $2.7M | 0% | Mar 2024 |
|
| Millennium Management | 63k | $1.8M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 55k | $1.6M | 100% | Mar 2024 |
|
| Skandinaviska Enskilda Banken AB | 44k | $1.3M | -13% | Mar 2024 |
|
| Fred Alger Management | 44k | $1.3M | 20% | Mar 2024 |
|
| Nuveen Asset Management | 40k | $1.2M | 10% | Mar 2024 |
|
| Charles Schwab Investment Management | 31k | $915k | 5% | Mar 2024 |
|
| Bank of New York Mellon | 28k | $818k | -24% | Mar 2024 |
|
| Morgan Stanley | 26k | $777k | 38% | Mar 2024 |
|
| Shay Capital | 25k | $727k | 100% | Mar 2024 |
|
| Two Sigma Investments | 23k | $678k | 135% | Mar 2024 |
|
| Springbok Capital Management | 21k | $612k | 100% | Mar 2024 |
|
| ALPS Advisors | 19k | $424k | -8% | Dec 2023 |
|
| Parkwood | 18k | $524k | 12% | Mar 2024 |
|
| D. E. Shaw & Co | 17k | $511k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 16k | $470k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 15k | $442k | 0% | Mar 2024 |
|
| Rhumbline Advisers | 15k | $432k | 3% | Mar 2024 |
|
| Alliancebernstein | 13k | $297k | 5% | Dec 2023 |
|
| PDT Partners | 13k | $375k | 100% | Mar 2024 |
|
| Jane Street | 11k | $333k | -14% | Mar 2024 |
|
| UBS Group | 11k | $332k | -8% | Mar 2024 |
|
| Golden State Equity Partners | 11k | $246k | 3% | Dec 2023 |
|
| Bank of America Corporation | 8.9k | $264k | -61% | Mar 2024 |
|
| Barclays | 7.9k | $233k | -49% | Mar 2024 |
|
| Two Sigma Advisers | 7.8k | $231k | 100% | Mar 2024 |
|
| American Century Companies | 7.1k | $211k | 100% | Mar 2024 |
|
| American International | 5.6k | $126k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 5.2k | $118k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 4.8k | $141k | -4% | Mar 2024 |
|
| Quest Partners | 4.6k | $137k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 4.6k | $136k | -39% | Mar 2024 |
|
| New York State Common Retirement Fund | 4.3k | $128k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 3.4k | $99k | 15% | Mar 2024 |
|
| Citigroup | 2.5k | $75k | 22% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.2k | $65k | -4% | Mar 2024 |
|
| Tower Research Capital | 2.1k | $61k | 43% | Mar 2024 |
|
| Legal & General Group | 1.2k | $35k | -29% | Mar 2024 |
|
| California State Teachers Retirement System | 1.1k | $33k | -90% | Mar 2024 |
|
| Summit Investment Advisors | 772.00 | $23k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 701.00 | $16k | 0% | Dec 2023 |
|
| Fortitude Family Office | 416.00 | $12k | 0% | Mar 2024 |
|
| Amalgamated Bank | 347.00 | $10k | -76% | Mar 2024 |
|
| Royal Bank of Canada | 287.00 | $9.0k | -92% | Mar 2024 |
|
| GAMMA Investing | 94.00 | $2.8k | 18% | Mar 2024 |
|
| NISA Investment Advisors | 7.00 | $206.999800 | 100% | Mar 2024 |
|
| Russell Investments | 7.00 | $206.999800 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $59.000000 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Aerovate Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Paradigm Biocapital Advisors | Dec 2023 | 143k | $3.2M |
| Hudson Bay Capital Management | Dec 2023 | 103k | $2.3M |
| Hrt Financial | Dec 2023 | 9.4k | $213k |